Re-188-Oncardia

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameRe-188-Oncardia

Drug Alias Name188Re-ethylenedicysteine-glucosamine188Re-EC-G

ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionDNA modulators

TargetsDNA

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCellPoint LLC

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCellPoint LLC

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A